Advances in the diagnostics of Alzheimer's disease

被引:0
|
作者
Fiedler, U. [1 ]
Wiltfang, J. [1 ]
Peters, N. [2 ]
Benninghoff, J. [1 ]
机构
[1] Univ Duisburg Essen, Kliniken & Inst, LVR Klinikum Essen, Gerontopsychiat Zentrum, D-45147 Essen, Germany
[2] Univ Spital Basel, Neurol Klin & Poliklin, Basel, Switzerland
来源
NERVENARZT | 2012年 / 83卷 / 05期
关键词
Dementia; Mild cognitive impairment; Alzheimer disease; Biomarker; Diagnostic criteria; MILD COGNITIVE IMPAIRMENT; ASSOCIATION WORKGROUPS; NATIONAL INSTITUTE; CLINICAL-USE; DEMENTIA; RECOMMENDATIONS; GUIDELINES; DEPRESSION; MRI;
D O I
10.1007/s00115-012-3486-9
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Due to the demographic developments, diagnosis and treatment, dementia constitutes an increasing medical challenge and is likely to have an increasing socioeconomic impact. Dementia does not reflect a single disease but encompasses a variety of underlying conditions, heterogeneous clinical courses and therapeutic approaches, among which Alzheimer's disease represents the most common cause. Therefore, a thorough differential diagnosis of dementia is of major importance. To date the current diagnosis of dementia according to ICD-10/DMS-IV is based on clinical criteria. In addition, the concept of mild cognitive impairment comprises early cognitive dysfunction without clinically apparent dementia. Alzheimer's disease is more and more conceptualized as a disease continuum with mild cognitive impairment as an early and manifest dementia as the later stage of the disease. This review gives an overview on the current diagnostic approaches and the proposed revisions of diagnostic and research criteria for Alzheimer's disease.
引用
收藏
页码:661 / 671
页数:11
相关论文
共 50 条
  • [41] Genetics of Alzheimer's disease: recent advances
    Dimitrios Avramopoulos
    Genome Medicine, 1
  • [42] Advances in Alzheimer’s Disease Drug Development
    Michael S Rafii
    Paul S Aisen
    BMC Medicine, 13
  • [43] Advances in the drug treatment of Alzheimer's disease
    Leonard, BE
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 1998, 13 (02) : 83 - 90
  • [44] Advances in Drug Therapy for Alzheimer's Disease
    Zhu, Chuan-cong
    Fu, Si-yu
    Chen, Yu-xin
    Li, Ling
    Mao, Ruo-lin
    Wang, Jian-zhi
    Liu, Rong
    Liu, Yi
    Wang, Xiao-chuan
    CURRENT MEDICAL SCIENCE, 2020, 40 (06): : 999 - 1008
  • [45] Advances in Modeling Alzheimer's Disease In Vitro
    Sharma, Navatha Shree
    Karan, Anik
    Lee, Donghee
    Yan, Zheng
    Xie, Jingwei
    ADVANCED NANOBIOMED RESEARCH, 2021, 1 (12):
  • [46] Alzheimer's Disease: Advances in Drug Development
    Piton, Morgane
    Hirtz, Christophe
    Desmetz, Caroline
    Milhau, Jacqueline
    Lajoix, Anne Dominique
    Bennys, Karim
    Lehmann, Sylvain
    Gabelle, Audrey
    JOURNAL OF ALZHEIMERS DISEASE, 2018, 65 (01) : 3 - 13
  • [47] Alzheimer's disease: Advances in molecular pathogenesis
    Cai, Dongming
    NEUROSCIENCE LETTERS, 2019, 711
  • [48] Volumetry of Insular Cortex in Diagnostics of Alzheimer's Disease
    Kremen, Jan
    Mrzilkova, Jana
    Bartos, Ales
    Ibrahim, Ibrahim
    Wurst, Zdenek
    Musil, Vladimir
    Kieslich, Karel
    Seremeta, Martin
    Kuchtova, Barbora Bircak
    Riedlova, Jitka
    Zach, Petr
    JOURNAL OF ANATOMY, 2020, 236 : 193 - 194
  • [49] Blood-based diagnostics of Alzheimer's disease
    Penner, Gregory
    Lecocq, Soizic
    Chopin, Anaelle
    Vedoya, Ximena
    Lista, Simone
    Vergallo, Andrea
    Lejeune, Francois-Xavier
    Hampel, Harald
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2019, 19 (07) : 613 - 621
  • [50] Alzheimer's Disease Diagnostics Must Be Globally Accessible
    Clute-Reinig, Nicholas
    Jayadev, Suman
    Rhoads, Kristoffer
    Le Ny, Anne-Laure
    JOURNAL OF ALZHEIMERS DISEASE, 2021, 84 (04) : 1453 - 1455